BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 9, 2005
View Archived Issues
Replidyne Raises $62.5M; Health Care Remains Top Dog For VCs
As its first product nears the market for respiratory infections, Replidyne Inc. brought in $62.5 million in a Series D round. (BioWorld Today)
Read More
Alliance Shifts Astral Subsidiary To MultiCell, Retains One-Third
Read More
Amicus Series C Garners $55M For Enzyme Efforts
Read More
Caliper Adding Size Through $22M NovaScreen Purchase
Read More
NeuroHealing Tackling Brain Injury With Dopamine Agonist
Read More
Life Science Firms Giving To Help Katrina's Victims
Read More
Other News To Note
Read More